|
|
???tair.name??? >
???browser.page.title.author???
|
"jiaang wt"???jsp.browse.items-by-author.description???
Showing items 26-50 of 86 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2017-03-21 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2016-12 |
Novel cKIT kinase inhibitor, BPRCKJ001, as an advanced therapeutic candidate for GIST
|
Shiao, HY;Tsai, HJ;Lin, WH;Tsu, TA;Yeh, TK;Chen, CT;Jiaang, WT |
| 國家衛生研究院 |
2016-10 |
BPR1J373, an oral multiple tyrosine kinase inhibitor, targets c-KIT for the treatment of c-KIT driven myeloid leukemia
|
Chen, LT;Chen, CT;Jiaang, WT;Chen, TY;Butterfield, JH;Shih, NY;Hsu, JT;Lin, HY;Lin, SF;Tsai, HJ |
| 國家衛生研究院 |
2016-08-30 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2016-04-12 |
Pyrazolylamine derivatives reveal the conformational switching between type I and type II binding modes of Anaplastic Lymphoma Kinase (ALK)
|
Tu, CH;Lin, WH;Peng, YH;Hsu, T;Wu, JS;Chang, CY;Lu, CT;Lyu, PC;Shih, C;Jiaang, WT;Wu, SY |
| 國家衛生研究院 |
2016-02-09 |
Pyrazole compounds and thiazole compounds as protein kinases inhibitors
|
Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS |
| 國家衛生研究院 |
2015-11-13 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2015-07 |
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations
|
Chen, CT;Hsu, JTA;Lin, WH;Lu, CT;Yen, SC;Hsu, T;Huang, YL;Song, JS;Chen, CH;Chou, LH;Yen, KJ;Chen, CP;Kuo, PC;Huang, CL;Eugene Liu, H;Chao, YS;Yeh, TK;Jiaang, WT |
| 國家衛生研究院 |
2014-08-01 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2014-05-12 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2014-05-08 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2014-04-25 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2014-04-21 |
作為蛋白質激酶抑制劑之吡唑化合物及噻唑化合物、其醫藥組成物及用途
|
Jiaang, WT;Hsu, TA;Lin, WH;Chao, YS |
| 國家衛生研究院 |
2014-02-19 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2014-02 |
Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation
|
Chung, KM;Hsu, SC;Chu, YR;Lin, MY;Jiaang, WT;Chen, RH;Chen, X |
| 國家衛生研究院 |
2014-01-08 |
Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer
|
Lin, WH;Yeh, TK;Jiaang, WT;Yen, KJ;Chen, CH;Huang, CT;Yen, SC;Hsieh, SY;Chou, LH;Chen, CP;Chiu, CH;Kao, LC;Chao, YS;Chen, CT;Hsu, JTA |
| 國家衛生研究院 |
2014-01 |
A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease
|
Yang, CC;Hu, HS;Wu, RH;Wu, SH;Lee, SJ;Jiaang, WT;Chern, JH;Huang, ZS;Wu, HN;Chang, CM;Yueh, A |
| 國家衛生研究院 |
2013-12-18 |
吡咯烷化合物
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2013-09-27 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2013-06-28 |
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor
|
Shiao, HY;Coumar, MS;Chang, CW;Ke, YY;Chi, YH;Chu, CY;Sun, HY;Chen, CH;Lin, WH;Fung, KS;Kuo, PC;Huang, CT;Chang, KY;Lu, CT;Hsu, JT;Chen, CT;Jiaang, WT;Chao, YS;Hsieh, HP |
| 國家衛生研究院 |
2013-06 |
Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)
|
Lin, WH;Hsu, JTA;Hsieh, SY;Chen, CT;Song, JS;Yen, SC;Hsu, T;Lu, CT;Chen, CH;Chou, LH;Yang, YN;Chiu, CH;Chen, CP;Tseng, YJ;Yen, KJ;Yeh, CF;Chao, YS;Yeh, TK;Jiaang, WT |
| 國家衛生研究院 |
2013-04-30 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2013-02-11 |
吡咯啉啶化合物
|
Jiaang, WT;Tsai, TY;Hsu, T;Chao, YS |
| 國家衛生研究院 |
2013-02-11 |
吡咯啶化合物
|
Jiaang, WT;Chen, X |
| 國家衛生研究院 |
2013-02 |
Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems
|
Lin, HM;Wang, JC;Hu, HS;Wu, PS;Wang, WH;Wu, SY;Yang, CC;Yeh, TK;Hsu, TA;Jiaang, WT;Chao, YS;Chern, JH;Yueh, A |
Showing items 26-50 of 86 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
|
